Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand

AIDS Research and Human Retroviruses

Volumn 26, Issue 10, 2010, Pages 1163-1166

  Briand, Nelly ^a,b   Le Coeur, Sophie ^b,c,d   Jourdain, Gonzague ^b,c,e   Hotrawarikarn, Somboon ^b,f   Sirinontakan, Surat ^b,g   Hinjiranandana, Temsiri ^b,h   Kanjanavanit, Suparat ^b,i   Traisathit, Patrinee ^b,c   McIntosh, Kenneth ^e,j   Lallemant, Marc ^b,c,e  

^a INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^b Institute of research for development Thailand   (Thailand)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d Inserm   (France)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Klaeng Hospital   (Thailand)

^g Health Promotion Hospital Regional Center i   (Thailand)

^h Somdej Pranangchao Sirikit Hospital   (Thailand)

ⁱ NAKORNPING HOSPITAL   (Thailand)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; ZIDOVUDINE;

ANEMIA; ARTICLE; BIRTH; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; LINEAR REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL; NEWBORN; PERINATAL INFECTION; PERINATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; THAILAND; VIRUS TRANSMISSION;

ANEMIA; CONFIDENCE INTERVALS; DRUG MONITORING; FEMALE; HEMATOLOGIC TESTS; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LINEAR MODELS; NEUTROPENIA; NEUTROPHILS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THAILAND; ZIDOVUDINE;

EID: 77958160785     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0034     Document Type: Article

References (7)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331(18):1173-1180.
2. Rapid advice: Use of antiretrovirals drugs for treating pregnant women and preventing HIV infections in infants. World Health Organization, Geneva, 2009.
3. Yeni P: Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts: Ministere de la Santé et des Solidarités, Paris, 2008.
4. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young N, et al.: Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353(9155):773-780.
5. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al.: Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial. Lancet 1999;353(9155):781-785.
6. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, et al.: A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000;343(14):982-991.
7. Aids Clinical Trials Group: Division of AIDS for grading the severity of adult and pediatric adverse events. National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS, Rockville, MD, 2004.